CDKN2A

Open Access
The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer
MIN HAN, SHIGEO YAMAGUCHI, MAI ONISHI, TOMOAKI FUJII, MASAKI HOSOYA, XUAN WEN, HIDENORI KIDO and SHUNSUKE KATO

Anticancer Research May 2022, 42 (5) 2277-2288; DOI: https://doi.org/10.21873/anticanres.15707
You have access
Expression of CK7 and CDKN2 in Cervical Intraepithelial Neoplasia and Correlation with Clinical Outcome
TATIANA MEGALE DE LIMA, GUSTAVO RUBINO DE AZEVEDO FOCCHI, BRUNA CRISTINE DE ALMEIDA, PATRICIA NAPOLI BELFORT-MATTOS, THAIS HEINKE and NEILA MARIA DE GÓIS SPECK

Anticancer Research December 2018, 38 (12) 6673-6681; DOI: https://doi.org/10.21873/anticanres.13035
You have access
BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells
MIKA OHTAKA, MAI ITOH and SHUJI TOHDA

Anticancer Research November 2017, 37 (11) 6047-6053;
You have access
Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas
DEMETRIOS MORIS, CHRISTOS DAMASKOS, ELEFTHERIOS SPARTALIS, ALEXANDROS PAPALAMPROS, SPYRIDON VERNADAKIS, DIMITRIOS DIMITROULIS, JOHN GRINIATSOS, EVANGELOS FELEKOURAS and NIKOLAOS NIKITEAS

Anticancer Research May 2017, 37 (5) 2185-2194;
You have access
PD-0332991, a Potent and Selective Inhibitor of Cyclin-dependent Kinase 4/6, Demonstrates Inhibition of Proliferation in Renal Cell Carcinoma at Nanomolar Concentrations and Molecular Markers Predict for Sensitivity
JOSHUA E. LOGAN, NIKAYEH MOSTOFIZADEH, AMRITA J. DESAI, ERIKA VON EUW, DYLAN CONKLIN, VEERAUO KONKANKIT, HABIB HAMIDI, MARK ECKARDT, LEE ANDERSON, HSIAO-WANG CHEN, CHARLES GINTHER, EILEEN TASCHEREAU, PETER H. BUI, JAMES G. CHRISTENSEN, ARIE S. BELLDEGRUN, DENNIS J. SLAMON and FAIROOZ F. KABBINAVAR

Anticancer Research August 2013, 33 (8) 2997-3004;

Main menu

User menu

Search

CDKN2A